Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001539497-25-003053 0001586094 XXXXXXXX LIVE 2 Common Stock, par value $0.01 per share 01/21/2026 false 0001520697 00404A109 Acadia Healthcare Company, Inc. 6100 TOWER CIRCLE SUITE 1000 FRANKLIN TN 37067 Eduard Skutelsky (646) 436-6643 COO of Khrom Capital Management LLC 1691 Michigan Ave., Suite 240 Miami FL 33139 0001586094 N Khrom Investments Fund, LP WC N DE 8124609.00 0.00 8124609.00 0.00 8124609.00 N 8.81 PN 0001877963 N Khrom Capital Management LLC WC N NY 0.00 8124609.00 0.00 8124609.00 8124609.00 N 8.81 IA 0002089455 N Eric Khrom WC N FL 6928.00 8124609.00 6928.00 8124609.00 8131537.00 N 8.81 IN Common Stock, par value $0.01 per share Acadia Healthcare Company, Inc. 6100 TOWER CIRCLE SUITE 1000 FRANKLIN TN 37067 This statement constitutes Amendment No. 2 to the Schedule 13D relating to the shares of common stock, par value $0.01 per share (the "Shares"), issued by Acadia Healthcare Company, Inc. (the "Issuer") and amends the Schedule 13D relating to the Shares originally filed by the Reporting Persons on October 1, 2025 (the "Original 13D") as amended by Amendment No. 1 to the Original Schedule 13D filed by the Reporting Persons on November 24, 2025 (as amended, this "Schedule 13D"). Capitalized terms used herein and not otherwise defined have the respective meanings ascribed thereto in the Original 13D. The responses of the Reporting Persons to Rows (7) through (11) of the cover pages of this Schedule 13D are incorporated herein by reference. The percentages set forth on the cover pages are based on 92,258,166 outstanding Shares as of November 4, 2025, as set forth in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 5, 2025. Khrom Investments is the direct beneficial owner of 8,124,609 Shares and Mr. Khrom is the direct beneficial owner of 6,928 Shares. The Shares reported as beneficially owned by Khrom Capital reflect the Shares that are directly beneficially owned by its affiliate, Khrom Investments, as Khrom Capital has the power to vote or direct the vote of (and the power to dispose or direct the disposition of) such Shares. Mr. Khrom is the sole member of Khrom Capital GP, LLC, which is the general partner of Khrom Investments. Mr. Khrom in his capacity as the managing member of Khrom Capital and as the sole member of Khrom Capital GP, LLC may be deemed to share the power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) the Shares directly beneficially owned by Khrom Investments and, accordingly, Mr. Khrom may be deemed to be the beneficial owner of such Shares. Mr. Khrom disclaims beneficial ownership of the Shares directly held by Khrom Investments except to the extent of any pecuniary interest therein. The information set forth in Item 5(a) is incorporated into this Item 5(b). Exhibit 1 attached hereto sets forth all transactions with respect to the Shares by any Reporting Person since November 24, 2025 (the date on which the last amendment to this Schedule 13D was filed with the SEC). No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Schedule 13D, except that dividends from, and proceeds from the sale of, the Shares held by the accounts managed by Khrom Capital, including the Shares that are directly beneficially owned by Khrom Investments, may be delivered to such accounts. Not applicable. 1. Transactions in Shares Khrom Investments Fund, LP /s/ Eduard Skutelsky Eduard Skutelsky / Chief Operating Officer 01/23/2026 Khrom Capital Management LLC /s/ Eduard Skutelsky Eduard Skutelsky / Chief Operating Officer 01/23/2026 Eric Khrom /s/ Eric Khrom Eric Khrom 01/23/2026